|
|
||||||||
Ann Thorac Surg 2002;73:233-238
© 2002 The Society of Thoracic Surgeons
a Department of Thoracic and Cardiovascular Surgery, J.W. Goethe University, Frankfurt/Main, Germany
b Cardiocentro Ticino, Lugano, Switzerland
c Department of Thoracic and Cardiovascular Surgery, University Hospitals, Homburg/Saar, Germany
Accepted for publication August 14, 2001.
* Address reprint requests to Dr Scherer, Department of Thoracic and Cardiovascular Surgery, J. W. Goethe University, Theodor-Stern-Kai 7, 60596 Frankfurt/Main, Germany
e-mail: m.scherer{at}em.uni-frankfurt.de
Background. Activation of the complement system and polymorphonuclear neutrophilic leukocytes plays a major role in mediating reperfusion injury after lung transplantation. We hypothesized that early interference with complement activation would reduce lung reperfusion injury after transplantation.
Methods. Unilateral left lung autotransplantation was performed in 6 sheep. After hilar stripping the left lung was flushed with Euro-Collins solution and preserved for 2 hours in situ at 15°C. After reperfusion the right main bronchus and pulmonary artery were occluded, leaving the animal dependent on the reperfused lung (reperfused group). C1-esterase inhibitor group animals (n = 6) received 200 U/kg body weight of C1-esterase inhibitor as a short infusion, half 10 minutes before, the other half 10 minutes after reperfusion. Controls (n = 6) underwent hilar preparation only. Pulmonary function was assessed by alveolar-arterial oxygen difference and pulmonary vascular resistance. The release of ß-N-acetylglucosaminidase served as indicator of polymorphonuclear neutrophilic leukocyte activation. Extravascular lung water was an indicator for pulmonary edema formation. Biopsy specimens were taken from all groups 3 hours after reperfusion for light and electron microscopy.
Results. In the reperfused group, alveolar-arterial oxygen difference and pulmonary vascular resistance were significantly elevated after reperfusion. All animals developed frank alveolar edema. The biochemical marker ß-N-acetylglucosaminidase showed significant leukocyte activation. In the C1-esterase inhibitor group, alveolar-arterial oxygen difference, pulmonary vascular resistance, and the level of polymorphonuclear neutrophilic leukocyte activation were significantly lower.
Conclusions. Treatment with C1-esterase inhibitor reduces reperfusion injury and improves pulmonary function in this experimental model.
Related Article
Ann. Thorac. Surg. 2002 73: 238-239.
This article has been cited by other articles:
![]() |
K. Baig, R. Nassar, D. M. Craig, G. Quick Jr, H. X. Jiang, M. M. Frank, A. J. Lodge, P. A.W. Anderson, and J. Jaggers Complement Factor 1 Inhibitor Improves Cardiopulmonary Function in Neonatal Cardiopulmonary Bypass Ann. Thorac. Surg., April 1, 2007; 83(4): 1477 - 1483. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Riedemann and P. A. Ward Complement in Ischemia Reperfusion Injury Am. J. Pathol., February 1, 2003; 162(2): 363 - 367. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |